SCHEMBL18504115

SCHEMBL18504115

c1ccc(-c2cccc(-c3cccc(-c4cccc(-c5cccc(-c6nc(-c7cc(-c8ccccc8)cc(-c8ccccc8)n7)nc7ccccc67)c5)c4)c3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ ATM Q13315 1/20 0.48
▸ ACHE P22303 1/20 0.45
▸ ADORA2A P29274 4/20 0.44
▸ DHODH Q02127 1/20 0.43
▸ NUDT1 P36639 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ PDE10A Q9Y233 1/20 0.42
▸ CYP19A1 P11511 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ RAB9A P51151 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18504114 0.92 MEN1 (0.49) MEN1KMT2AATMACHEADORA2A
SCHEMBL18504045 0.91 MEN1 (0.48) MEN1KMT2AATMACHEADORA2A
SCHEMBL18503992 0.91 MEN1 (0.48) MEN1KMT2AATMACHEADORA2A
SCHEMBL17721015 0.90 MEN1 (0.58) MEN1KMT2AATMACHEADORA2A
SCHEMBL17412679 0.88 MEN1 (0.59) MEN1KMT2AATMACHEADORA2A
SCHEMBL18504113 0.87 MEN1 (0.61) MEN1KMT2AATMADORA2ANUDT1
SCHEMBL18504014 0.87 MEN1 (0.57) MEN1KMT2AATMADORA2ANUDT1
SCHEMBL18504105 0.87 MEN1 (0.57) MEN1KMT2AATMADORA2ANUDT1
SCHEMBL18504106 0.87 MEN1 (0.57) MEN1KMT2AATMADORA2ANUDT1
SCHEMBL16436795 0.86 MEN1 (0.65) MEN1KMT2AATMACHEADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 — — US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 — — US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 MEN1 1724/4885KMT2A 4198/4885ATM 4155/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 MEN1 1724/4885KMT2A 4198/4885ATM 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback